Literature DB >> 15203242

Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor.

Mélanie Van Craenenbroeck1, Françoise Gregoire, Philippe De Neef, Patrick Robberecht, Jason Perret.   

Abstract

Ghrelin, a 28 residues acylated peptide, is the natural ligand of the growth-hormone secretagogue receptor (GHS-R), which also interacts with small synthetic peptides. We investigated the importance of each of the first 14 N-terminal residues by Ala replacement (Ala-scan) and also of the N-terminal positive charge, on the recombinant GHS-R expressed in HEK293 or CHO cells by binding, IP and Ca(2+) assays. Nearly all of the replacements had no significant effect on the ligand binding or IP(3)/Ca(2+) stimulation. Exceptions were the modification of the N-terminal residue to [A(1)]- or N(alpha)-acetyl-ghrelin (1-14), confirming the requirement for the positive charge at the amino-terminus. Mutation of [F(4)]- to [A(4)]- or [Y(4)]-ghrelin (1-14), were detrimental suggesting direct interaction with the GHS-R. [A(8)] and [Y(8)] were more potent than ghrelin (1-14), implying that the naturally occurring Glu(8) residue may not be the optimal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203242     DOI: 10.1016/j.peptides.2004.03.010

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

1.  Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.

Authors:  Delphine Mousseaux; Lionel Le Gallic; Joanne Ryan; Catherine Oiry; Didier Gagne; Jean-Alain Fehrentz; Jean-Claude Galleyrand; Jean Martinez
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

2.  Development of a [68Ga]-ghrelin analogue for PET imaging of the ghrelin receptor (GHS-R1a).

Authors:  C L Charron; M S McFarland; S Dhanvantari; L G Luyt
Journal:  Medchemcomm       Date:  2018-09-17       Impact factor: 3.597

3.  Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro.

Authors:  T Kitazawa; B De Smet; K Verbeke; I Depoortere; T L Peeters
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

4.  Structure and dynamics of G protein-coupled receptor-bound ghrelin reveal the critical role of the octanoyl chain.

Authors:  Guillaume Ferré; Maxime Louet; Oliver Saurel; Bartholomé Delort; Georges Czaplicki; Céline M'Kadmi; Marjorie Damian; Pedro Renault; Sonia Cantel; Laurent Gavara; Pascal Demange; Jacky Marie; Jean-Alain Fehrentz; Nicolas Floquet; Alain Milon; Jean-Louis Banères
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-15       Impact factor: 11.205

5.  In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences.

Authors:  Julien Dimastromatteo; Alexis Broisat; Pascale Perret; Mitra Ahmadi; Didier Boturyn; Pascal Dumy; Daniel Fagret; Laurent M Riou; Catherine Ghezzi
Journal:  J Nucl Med       Date:  2013-05-29       Impact factor: 10.057

6.  Structural Model of Ghrelin Bound to its G Protein-Coupled Receptor.

Authors:  Brian Joseph Bender; Gerrit Vortmeier; Stefan Ernicke; Mathias Bosse; Anette Kaiser; Sylvia Els-Heindl; Ulrike Krug; Annette Beck-Sickinger; Jens Meiler; Daniel Huster
Journal:  Structure       Date:  2019-01-24       Impact factor: 5.006

Review 7.  Structure and physiological actions of ghrelin.

Authors:  Christine Delporte
Journal:  Scientifica (Cairo)       Date:  2013-11-28

8.  Side Chain Orientation of Tryptophan Analogues Determines Agonism and Inverse Agonism in Short Ghrelin Peptides.

Authors:  Lennart Nicke; Ronny Müller; Armin Geyer; Sylvia Els-Heindl
Journal:  ChemMedChem       Date:  2019-09-16       Impact factor: 3.466

Review 9.  The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors.

Authors:  Oanh Vu; Brian Joseph Bender; Lisa Pankewitz; Daniel Huster; Annette G Beck-Sickinger; Jens Meiler
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

Review 10.  A Decade's Progress in the Development of Molecular Imaging Agents Targeting the Growth Hormone Secretagogue Receptor.

Authors:  Marina D Childs; Leonard G Luyt
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.